Study protocol for a randomised, placebo-controlled, single-blind phase II study of the efficacy of morphine for dyspnoea in patients with interstitial lung disease (JORTC-PAL 15)

INTRODUCTION: Dyspnoea is common in patients with interstitial lung disease (ILD) and often refractory to conventional treatment. Little is known about the efficacy of systemic morphine for dyspnoea in patients with ILD. The aim of this study is to estimate the efficacy of a single subcutaneous morp...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Open
Asıl Yazarlar: Matsuda, Yoshinobu, Morita, Tatsuya, Oyamada, Shunsuke, Ariyoshi, Keisuke, Yamaguchi, Takuhiro, Iwase, Satoru
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Respiratory Medicine
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8130746/
https://ncbi.nlm.nih.gov/pubmed/34006542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-043156
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller